TOBAM’s Bio-Rad Laboratories Class A BIO Stock Holding History

TOBAM’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-150	Closed	-$57K	–	377
2023 Q2	$57K	Buy	+150	New	+$61K	﹤0.01%	349
2023 Q1	–	Sell	-72	Closed	-$30K	–	368
2022 Q4	$30K	Sell	72 -26	-27%	-$10.5K	﹤0.01%	380
2022 Q3	$41K	Hold	98	–	–	﹤0.01%	378
2022 Q2	$49K	Hold	98	–	–	﹤0.01%	381
2022 Q1	$55K	Buy	98 +26	+36%	+$15.7K	﹤0.01%	383
2021 Q4	$54K	Hold	72	–	–	﹤0.01%	341
2021 Q3	$54K	Hold	72	–	–	﹤0.01%	347
2021 Q2	$46K	Hold	72	–	–	﹤0.01%	352
2021 Q1	$41K	Hold	72	–	–	﹤0.01%	365
2020 Q4	$42K	Hold	72	–	–	﹤0.01%	352
2020 Q3	$37K	Buy	+72	New	+$36.5K	﹤0.01%	339

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Millennium Management

Millennium Management New York $134B AUM 35.51% 1-Year Est. Return